Lonza to set up Singapore cell therapy plant
Swiss biomedical science firm Lonza is investing CHF30m (€19.7m) in a new cell therapy facility in Singapore, continuing its global expansion effort.
Archives for May 21, 2009
Hovione to invest €2m in nano drug R&D unit
Portuguese contract manufacturing organisation (CMO) Hovione plans to invest €2m ($3m) in a new R&D unit in the capital Lisbon, as expansion space at its active pharmaceutical ingredient (API) plant in Loures is limited.
BIO 2009: snapshot of an evolving biotech industry
in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.